Stay updated on Efficacy & Safety of M2951 in Relapsing MS Clinical Trial
Sign up to get notified when there's something new on the Efficacy & Safety of M2951 in Relapsing MS Clinical Trial page.

Latest updates to the Efficacy & Safety of M2951 in Relapsing MS Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedA new revision tag v3.6.3 appears, replacing the previous v3.6.2, signaling a minor version update to the page's software. This update does not modify the study content or visible details.SummaryDifference0.0%

- Check17 days agoChange DetectedA newer revision (v3.6.2) has been added, replacing the previous revision (v3.6.0) in the study documents section.SummaryDifference0.0%

- Check32 days agoChange DetectedNew navigation and help sections were added, including How to Read a Study Record, Common Questions, How to Join a Study, and an updated Intervention/Treatment heading. The recruitment status was changed to No longer looking for participants, indicating enrollment has ended.SummaryDifference0.3%

- Check39 days agoChange DetectedThe page now displays Revision: v3.5.5 in place of Revision: v3.5.4, indicating a recent minor update to the page's revision metadata. This update does not alter visible content or functionality.SummaryDifference0.0%

- Check60 days agoChange DetectedA new revision label, v3.5.4, has been added, replacing the previous v3.5.3. This reflects a minor update to the page’s content or presentation, rather than changes to core study information.SummaryDifference0.0%

- Check81 days agoChange DetectedThe page’s footer software revision was updated from **v3.5.2** to **v3.5.3**.SummaryDifference0.0%

Stay in the know with updates to Efficacy & Safety of M2951 in Relapsing MS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy & Safety of M2951 in Relapsing MS Clinical Trial page.